tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AMRX Stock Latest News

Amneal Pharmaceuticals announces expanded coverage for Crexont
The FlyAmneal Pharmaceuticals announces expanded coverage for Crexont
14d ago
CVS
UNH
Amneal Pharmaceuticals announces U.S. launch of Boruzu
PremiumThe Fly
Amneal Pharmaceuticals announces U.S. launch of Boruzu
16d ago
AMRX
Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment
PremiumMarket News
Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment
1M ago
AMRX
Amneal Pharmaceuticals BLA submissions for denosumab biosimilars accepted by FDA
PremiumThe Fly
Amneal Pharmaceuticals BLA submissions for denosumab biosimilars accepted by FDA
1M ago
AMRX
Amneal Pharmaceuticals price target raised to $11 from $10 at Barclays
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $11 from $10 at Barclays
2M ago
AMRX
Amneal Pharmaceuticals Reports Strong 2024 Financial Results
PremiumCompany AnnouncementsAmneal Pharmaceuticals Reports Strong 2024 Financial Results
2M ago
AMRX
Amneal Pharmaceuticals’ Earnings Call Highlights Robust Growth
Premium
Company Announcements
Amneal Pharmaceuticals’ Earnings Call Highlights Robust Growth
2M ago
AMRX
Amneal Pharmaceuticals Reports Strong 2024 Financial Growth
Premium
Company Announcements
Amneal Pharmaceuticals Reports Strong 2024 Financial Growth
2M ago
8K
AMRX
Amneal Pharmaceuticals sees FY25 CapEx ~$100M
PremiumThe Fly
Amneal Pharmaceuticals sees FY25 CapEx ~$100M
2M ago
AMRX
Amneal Pharmaceuticals reports Q4 adjusted EPS 12c, consensus 15c
PremiumThe Fly
Amneal Pharmaceuticals reports Q4 adjusted EPS 12c, consensus 15c
2M ago
AMRX
Amneal Pharmaceuticals sees FY25 adjusted EPS 65c-75c, consensus 71c
PremiumThe Fly
Amneal Pharmaceuticals sees FY25 adjusted EPS 65c-75c, consensus 71c
2M ago
AMRX
AMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AMRX
Amneal Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
PremiumThe FlyAmneal Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
2M ago
AMRX
Robust Growth and Strategic Positioning Drive Buy Rating for Amneal Pharmaceuticals
Premium
Ratings
Robust Growth and Strategic Positioning Drive Buy Rating for Amneal Pharmaceuticals
2M ago
AMRX
Amneal launches Mesalamine; receives U.S. FDA Lenalidomide approval
Premium
The Fly
Amneal launches Mesalamine; receives U.S. FDA Lenalidomide approval
2M ago
AMRX
Amneal gets FDA approval for memantine/donepezil extended-release capsules
PremiumThe Fly
Amneal gets FDA approval for memantine/donepezil extended-release capsules
3M ago
AMRX
Amneal receives FDA tentative approval for ANDA for rifaximin
PremiumThe Fly
Amneal receives FDA tentative approval for ANDA for rifaximin
3M ago
AMRX
Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
PremiumThe Fly
Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
3M ago
AMRX
Amneal Pharmaceuticals Maintains Transparency with SEC Filing
PremiumCompany Announcements
Amneal Pharmaceuticals Maintains Transparency with SEC Filing
3M ago
8K
AMRX
Amneal Pharmaceuticals director Patel sells 62,590 class A shares
PremiumThe FlyAmneal Pharmaceuticals director Patel sells 62,590 class A shares
3M ago
AMRX
Appeals court sides with Amneal over Teva in inhaler patent fight
Premium
The Fly
Appeals court sides with Amneal over Teva in inhaler patent fight
4M ago
AMRX
TEVA
Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide
Premium
The Fly
Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide
5M ago
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >